Table 1.
Study schedule
| Time point | t0 | Day 1 | Each 48 h | Day of outcomea |
|---|---|---|---|---|
| Study procedures | ||||
| Recruitment | ✓ | |||
| Eligibility screening | ✓ | |||
| Informed consent form | ✓ | |||
| Assessments | ||||
| Case report form (Demographic + clinical data) | ✓ | |||
| RT-PCR SARS-CoV-2 test (sensitivity) | ✓ | (✓)b | (✓)b | |
| Digital auscultation collection | ||||
| COVID-positive recruited in triage sites | ✓ | (✓)c | (✓)c | (✓)c,d |
| COVID-positive recruited as inpatients | ✓ | ✓ | ✓ | (✓)d |
| COVID-negative patients | ✓ |
✓: performed, (✓): performed with stipulated conditions
aIf recruited in triage sites: (1) No hospitalisation within 7 days of enrolment, (2) hospitalisation within 7 days of enrolment with discharge, (3) hospitalisation within 7 days of enrolment with ICU admission/death
If recruited as inpatients: (1) Discharge with without worsened condition attributable to COVID-19, (2) Worsened condition attributable to COVID-19 with ICU admission/death
bIf initially negative and remains symptomatic with renewed testing criteria
cIf later hospitalised
dNot collected once admitted to intensive care